Clinical Trials Logo

Abiraterone ACetate clinical trials

View clinical trials related to Abiraterone ACetate.

Filter by:
  • None
  • Page 1

NCT ID: NCT04735913 Recruiting - Pharmacokinetic Clinical Trials

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

Start date: May 5, 2020
Phase: Early Phase 1
Study type: Interventional

1. To explore the relationship between the changes of plasma concentration of abiraterone acetate after taken orally on fasting or postprandial and gene polymorphism. 2. Study of drug Metabolite profiling after oral administration of abiraterone acetate on fasting and postprandial in Chinese adults.

NCT ID: NCT02787837 Active, not recruiting - Clinical trials for Advanced Prostate Cancer

PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.

PROSABI
Start date: May 2014
Phase:
Study type: Observational

PROSABI is a prospective multicentre observational study in metastatic Castration-Resistant Prostate Cancer (mCRPC), designed to explore prognostic biomarkers in patients undergoing treatment with abiraterone